D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 83 Citations 24,313 766 World Ranking 8407 National Ranking 245

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Disease

Transplantation, Internal medicine, Hematopoietic stem cell transplantation, Surgery and Immunology are his primary areas of study. His studies deal with areas such as Transplantation Conditioning, Stem cell and Chemotherapy as well as Transplantation. His Internal medicine research incorporates themes from Gastroenterology and Oncology.

Mohamad Mohty works mostly in the field of Hematopoietic stem cell transplantation, limiting it down to concerns involving Intensive care medicine and, occasionally, Cancer and Clinical trial. The study incorporates disciplines such as Cumulative incidence and Hazard ratio in addition to Surgery. His research investigates the connection between Immunology and topics such as Progenitor cell that intersect with issues in Plerixafor.

His most cited work include:

  • Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial. (453 citations)
  • The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach (275 citations)
  • Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories (243 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Surgery. His study connects Gastroenterology and Internal medicine. His Gastroenterology study combines topics in areas such as Total body irradiation and Bone marrow.

His research integrates issues of Regimen, Stem cell and Immunology in his study of Transplantation. His Oncology research focuses on Multiple myeloma and how it relates to Dexamethasone. His Hematopoietic stem cell transplantation research integrates issues from Survival rate, Transplantation Conditioning, Human leukocyte antigen and Retrospective cohort study.

He most often published in these fields:

  • Internal medicine (80.72%)
  • Transplantation (74.98%)
  • Oncology (36.68%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (80.72%)
  • Transplantation (74.98%)
  • Oncology (36.68%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Transplantation, Oncology, Acute leukemia and Gastroenterology. His work is connected to Myeloid leukemia, Cyclophosphamide, Hematopoietic stem cell transplantation, Incidence and Hazard ratio, as a part of Internal medicine. He is involved in the study of Transplantation that focuses on Graft-versus-host disease in particular.

Mohamad Mohty has researched Oncology in several fields, including Refractory, Chemotherapy, Cohort, Regimen and Multiple myeloma. The concepts of his Acute leukemia study are interwoven with issues in Multivariate analysis, Marrow transplantation and Lymphoblastic Leukemia. His studies deal with areas such as Progressive disease, Human leukocyte antigen and Cumulative incidence as well as Gastroenterology.

Between 2019 and 2021, his most popular works were:

  • Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease (74 citations)
  • Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) (63 citations)
  • COVID-19 outcomes in patients with hematologic disease. (59 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

Mohamad Mohty mostly deals with Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Disease. Many of his studies on Internal medicine apply to Gastroenterology as well. Mohamad Mohty studies Graft-versus-host disease, a branch of Transplantation.

His Oncology study incorporates themes from Refractory, Chemotherapy, Lymphoma, Chimeric antigen receptor and Multiple myeloma. His Hematopoietic stem cell transplantation research is multidisciplinary, relying on both Hematology, Pandemic and Retrospective cohort study. His study in Disease is interdisciplinary in nature, drawing from both Metagenomics, Randomized controlled trial and Immunology, Vaccination.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.

Jean-Luc Harousseau;Michel Attal;Hervé Avet-Loiseau;Gerald Marit.
Journal of Clinical Oncology (2010)

697 Citations

Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

Jakob Passweg;H. Baldomero;P. Bader;Chiara Bonini.
Bone Marrow Transplantation (2016)

401 Citations

Graft-Versus-Lymphoma Effect for Aggressive T-Cell Lymphomas in Adults: A Study by the Société Française de Greffe de Moëlle et de Thérapie Cellulaire

Steven Le Gouill;Noel Milpied;Agnès Buzyn;Régis Peffault De Latour.
Journal of Clinical Oncology (2008)

358 Citations

The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

Jan J. Cornelissen;Alois Gratwohl;Richard F. Schlenk;Jorge Sierra.
Nature Reviews Clinical Oncology (2012)

357 Citations

Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories

Régis Peffault de Latour;Jean Yves Mary;Célia Salanoubat;Louis Terriou.
Blood (2008)

348 Citations

One million haemopoietic stem-cell transplants: a retrospective observational study

Alois Gratwohl;Marcelo C Pasquini;Mahmoud Aljurf;Yoshiko Atsuta.
The Lancet Haematology (2015)

292 Citations

Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis

Salut Brunet;Myriam Labopin;Jordi Esteve;Jan Cornelissen.
Journal of Clinical Oncology (2012)

285 Citations

Reduced Intensity Conditioning Compared With Myeloablative Conditioning Using Unrelated Donor Transplants in Patients With Acute Myeloid Leukemia

Olle Ringdén;Myriam Labopin;Gerhard Ehninger;Dietger Niederwieser.
Journal of Clinical Oncology (2009)

278 Citations

Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Celso A. Rodrigues;Guillermo Sanz;Claudio G. Brunstein;Jaime Sanz.
Journal of Clinical Oncology (2009)

277 Citations

Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

T. Ruutu;A. Gratwohl;T. De Witte;B. Afanasyev.
Bone Marrow Transplantation (2014)

268 Citations

Editorial Boards

Bone Marrow Transplantation
(Impact Factor: 5.174)

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mohamad Mohty

Xiao-Jun Huang

Xiao-Jun Huang

Peking University

Publications: 163

Arnon Nagler

Arnon Nagler

Sheba Medical Center

Publications: 102

Sergio Giralt

Sergio Giralt

Memorial Sloan Kettering Cancer Center

Publications: 98

Hillard M. Lazarus

Hillard M. Lazarus

Case Western Reserve University

Publications: 94

Nicolaus Kröger

Nicolaus Kröger

Universität Hamburg

Publications: 88

Brenda M. Sandmaier

Brenda M. Sandmaier

Fred Hutchinson Cancer Research Center

Publications: 87

Daniel J. Weisdorf

Daniel J. Weisdorf

University of Minnesota

Publications: 82

Bipin N. Savani

Bipin N. Savani

Vanderbilt University Medical Center

Publications: 81

Miguel-Angel Perales

Miguel-Angel Perales

Memorial Sloan Kettering Cancer Center

Publications: 77

Philippe Moreau

Philippe Moreau

University of Nantes

Publications: 70

Meletios A. Dimopoulos

Meletios A. Dimopoulos

National and Kapodistrian University of Athens

Publications: 69

Richard E. Champlin

Richard E. Champlin

The University of Texas MD Anderson Cancer Center

Publications: 69

Rainer Storb

Rainer Storb

Fred Hutchinson Cancer Research Center

Publications: 67

Paul G. Richardson

Paul G. Richardson

Harvard University

Publications: 66

Jakob Passweg

Jakob Passweg

University Hospital of Basel

Publications: 65

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 60

Trending Scientists

Guang R. Gao

Guang R. Gao

University of Delaware

Benny Chor

Benny Chor

Tel Aviv University

Helen Lingard

Helen Lingard

RMIT University

Barbara J. Finlayson-Pitts

Barbara J. Finlayson-Pitts

University of California, Irvine

Jing Zhang

Jing Zhang

Wuhan University

Tao Zhang

Tao Zhang

Jiangnan University

John G. Scandalios

John G. Scandalios

North Carolina State University

Ann Harris

Ann Harris

Case Western Reserve University

Susan B. Watson

Susan B. Watson

Environment and Climate Change Canada

Dean E. Pearson

Dean E. Pearson

University of Montana

José V. Castell

José V. Castell

University of Valencia

Tatsuya Kunisue

Tatsuya Kunisue

Ehime University

Rita J. Balice-Gordon

Rita J. Balice-Gordon

University of Pennsylvania

Marc Buyse

Marc Buyse

Hasselt University

Joke Voogt

Joke Voogt

University of Amsterdam

Amarjit Soni

Amarjit Soni

Brookhaven National Laboratory

Something went wrong. Please try again later.